Although lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) have different pathological and clinical features, they may share common driver genes. It was found that lipid levels can be used for early diagnosis of NSCLC; however, the relationship between driver genes and genes regulating lipid metabolism and their relationship with patient prognosis needs further investigation.

中文翻译：

---

TOP2A和ADH1B与肺腺癌和鳞癌患者血脂水平和预后的关系

尽管肺腺癌（LUAD）和肺鳞状细胞癌（LUSC）具有不同的病理和临床特征，但它们可能具有共同的驱动基因。研究发现血脂水平可用于NSCLC的早期诊断；然而，驱动基因和脂质代谢调节基因之间的关系及其与患者预后的关系还需要进一步研究。